Genomic research in this area uncovered SNPs in the interleukin-18 (IL-18) gene and its promoter, which were associated with chronic hepatitis and development of HCC among chronic hepatitis B patients, respectively [59],[60]. The gene discussed is IL18; the disease is hepatocellular carcinoma.